Evidence first
We only work with modalities backed by human clinical research, and we say clearly where the evidence is strong and where it is still early.
Luminerve brings precise, non-invasive energy-based therapies to integrative and natural health practitioners. Chosen for the strength of their evidence. Delivered with education and clinical support. Designed to sit alongside the care you already give.
The body already runs on energy. We help practitioners work with it, precisely.

Every nerve signal is electrical. Every cell holds light-sensitive enzymes in its mitochondria. Living tissue responds to changing magnetic fields. This is basic physiology, studied for decades.
Natural medicine has always worked with the body's own capacity to regulate and repair. Bioelectronic medicine extends that principle, using small, carefully measured doses of energy instead of another compound to swallow.
Luminerve exists to bring the best of this field into natural and integrative practice, with the evidence, education and regulatory care that practitioners and their patients deserve.
Energy-based therapies attract big promises. We would rather earn trust slowly, with clear evidence and honest limits.
We only work with modalities backed by human clinical research, and we say clearly where the evidence is strong and where it is still early.
Dose matters. Frequency, wavelength, intensity and duration are specified, documented and reproducible.
Every device we supply will be included on the Australian Register of Therapeutic Goods before it reaches a clinic.
Built for clinicians who assess, prescribe and review, and designed to complement herbal medicine, nutrition and lifestyle care.
What separates a convincing clinical trial from a disappointing gadget is usually delivery: where the energy goes, how much of it arrives, and for how long. That is where Luminerve does its work.
The vagus nerve is the body's main line of communication between the brain and the organs. The outer ear is the one place a branch of it runs just beneath the skin, which makes it reachable without surgery.
When brain imaging compared four sites on the ear, only this small hollow produced significantly stronger activation of the brainstem's vagal relay centres than placebo. The earlobe, a common clip site, is what researchers use as the placebo.
Red and near-infrared light is absorbed by cytochrome c oxidase, a key enzyme in the mitochondria, where cells make their energy. Near-infrared wavelengths can pass through the scalp and skull to reach the brain itself.
Only a small fraction of light survives the journey through the skull, so placement, wavelength and power density decide whether the cortex receives a meaningful dose. We aim at this hub of attention, planning and emotional regulation, and we specify dose in joules per square centimetre, not minutes.
Time-varying magnetic fields pass through clothing, skin and bone without contact. Inside tissue they induce small electrical currents that influence how cells signal to one another.
Magnetic fields are invisible, which makes it easy to sell very little of them. Many wellness mats emit fields measured in microtesla. We specify fields in the millitesla range, with the frequencies and pulse patterns used in clinical research.
The right anatomical target, chosen from imaging and anatomy research, not convenience.
A dose that matches the trials: current, wavelength, power density or field strength, stated in real units.
Session length and frequency drawn from the research, taught to practitioners with an evidence grade.
Many chronic health concerns trace back to a small number of regulatory systems. Each of our three energies acts on several of them, and together they reach the brain, the autonomic and immune systems, cellular energy, circulation and the body's structure.
Energy-based therapies act on regulatory systems. Herbs, nutrients, diet, movement and sleep supply the raw materials and help hold the gains. We see these devices as a new set of levers within natural medicine, not a replacement for it.
Before anything reaches a practitioner, it passes four gates. Most candidates do not.
Controlled human trials, not only cell or animal studies. We read the full papers, not the abstracts.
The device must deliver the parameters the research actually used, and we check this ourselves.
Australian inclusion on the ARTG, with honest, on-label information for every device.
Practitioner training, screening and safety guidance, and ongoing clinical support.
We are developing Luminerve with a small group of Australian practitioners. Register your interest to hear first about our education program and launch.